Legacy claim assessment · corrected
Retain the supported underwriting use while removing unsubstantiated life/disability scope, multi-source applicant ingestion and manual-review replacement claims.
Assessed Nov 8, 2026. This verdict is separate from deployment evidence and measured outcomes.
Catalog record · Lending & Credit
Stage as of Dec 31, 2025 · historical report, not live reconfirmation.
AI predictive modelling for insurance underwriting
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Nov 8, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
MetLife reports applying AI-driven predictive modelling in underwriting to improve pricing accuracy and speed.
Original catalog wording · AI Underwriting Automation
MetLife applies AI to automate life and disability insurance underwriting, analyzing applicant data from multiple sources to make faster and more consistent risk assessments. The system processes applications that previously required manual review, improving turnaround times and underwriting accuracy.
Archived maturity label: Production. Retained as original wording, not a current deployment assertion.
Original catalog sourcemetlife.com · opens in a new tabAudited correction: Source-bound legacy adjudication. Retain the supported underwriting use while removing unsubstantiated life/disability scope, multi-source applicant ingestion and manual-review replacement claims. Original catalog wording is archived; unsupported historical impact ratings, generated summaries and unestablished announcement dates are cleared. Updated fields: title, description, summary, categoryId, maturity, aiTechnology, businessFunction, impact, sourceUrl, sourceType, announcedDate.
- Reported stage
- Production
- Technology
- Machine Learning / predictive modelling
- Business function
- Middle Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Mar 13, 2026
- Last researched
- Nov 8, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
The CEO's 2025 shareholder letter describes an operating underwriting application. Status as of 2025-12-31.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Nearby call-centre, claims and expense figures are not underwriting outcomes. Model architecture, product lines, rollout geography and quantified underwriting impact are undisclosed.
Source register
- 2025 CEO Letter to Shareholderss201.q4cdn.com · opens in a new tab
MetLife · issuer · full-text · Publication date not recorded
Research lanes: legacy-5 · Batch research-refresh-2026-11-08. Coverage and remaining gaps